Robyn van Poelgeest

Robyn van Poelgeest is a seasoned medical professional currently serving as the Medical Director of Global Medical Affairs at Sarepta Therapeutics since September 2023. Prior roles include Director of Global Medical Affairs at The Janssen Pharmaceutical Companies of Johnson & Johnson and various positions at Merck, where responsibilities encompassed business strategy and medical science liaison roles in anesthesiology, surgery, and neurosciences. Robyn's earlier experience includes serving as a Medical Research Scientist at the Texas Center for Drug Development and as a Resident Physician and Clinical Scholar at Cedars-Sinai, focusing on pain management and neurodegenerative diseases. Robyn holds both a Doctor of Medicine and a Doctor of Philosophy in Neuroscience from Texas A&M University School of Medicine.